Amgen’s $27.8bn Horizon Takeover Stipulates Biosimilar Restrictions

Biosimilar Restraint Part Of Litany Of New Considerations For Big Pharma Buyers

Man Controlling Trade statue in front of the Federal Trade Commission Building
• Source: Shutterstock

More from Deals

More from Business